L'information officielle sur les médicaments
Base de Données Publique des Médicaments (medicaments.gouv.fr) scores 63 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, Government brands, in the 9th percentile of 7318 Healthcare brands.
Base de Données Publique des Médicaments (medicaments.gouv.fr) is an official French government platform providing public access to information about medicines, their active substances, and related pathologies. It is operated under the Ministère du Travail, de la Santé, des Solidarités et des Familles and allows users to search by medicine name, active substance, or pathology. The platform serves as a reference for health professionals, patients, and the general public seeking verified medication information in France.
| Brand Name | Base de Données Publique des Médicaments |
|---|---|
| Domain | medicaments.gouv.fr |
| Industry | Healthcare, Government |
| Parent Company / Owner | Ministère du Travail, de la Santé, des Solidarités et des Familles |
| Main Competitors | Vidal (84/100), Théoriaque (67/100), Agence nationale de sécurité du médicament (ANSM), European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA) Drug Database (88/100), Compendium Suisse des Médicaments |
Moz Domain Authority 58/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Fournir un accès public et officiel aux informations sur les médicaments, leurs substances actives et les pathologies associées." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is FR-only, limiting citation in English-language AI answers.
Social footprint: verified profiles on GitHub, Facebook, Instagram; no detected presence on X (Twitter), LinkedIn, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked September 2026.
When asked "What is Base de Données Publique des Médicaments?", Claude could identify the brand as of September 2026. It's the French government's official public database of medicines, run by the ANSM (French health products safety agency) and the health ministry, providing details on approved drugs sold in France including their composition, indications, side effects, and official leaflets. Best known for Being the official French public reference database for drug information, including package inserts (notices) and marketing authorizations.
When asked "Best brands similar to Base de Données Publique des Médicaments?", Claude would recommend Base de Données Publique des Médicaments as of September 2026. It's the authoritative go-to source for anyone in France needing official, government-verified information on medications.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Base de Données Publique des Médicaments's main competitors in Healthcare: Vidal (84/100), Théoriaque (67/100), U.S. Food and Drug Administration (FDA) Drug Database (88/100).
Sources: Brand Analyzer scan
Yes, it is trustworthy as it is an official platform operated by the French Ministère du Travail, de la Santé, des Solidarités et des Familles, positioning it as the reliable public reference for medication information in France.
Sources: Base de Données Publique des Médicaments official site
The platform offers a searchable public database of medicines, including information on their active substances and the pathologies they are used to treat. It allows searches by medicine name, active substance, or condition to retrieve official medication data.
Sources: Base de Données Publique des Médicaments official site
Base de Données Publique des Médicaments (medicaments.gouv.fr) is an official French government website that provides public access to information about medicines, their active substances, and associated pathologies. It is maintained under the authority of the Ministère du Travail, de la Santé, des Solidarités et des Familles and functions as an official reference source for medication data in France.
Sources: Base de Données Publique des Médicaments official site
Base de Données Publique des Médicaments has limited AI-search visibility, scoring 25/100 on Brand Analyzer's AI visibility composite (visibility 15, trust 22, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Base de Données Publique des Médicaments official site
Base de Données Publique des Médicaments scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Base de Données Publique des Médicaments official site
Base de Données Publique des Médicaments can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Base de Données Publique des Médicaments official site
The platform is used by health professionals, patients, and the general public in France who are seeking verified information about medicines and treatments available in the country.
Sources: Base de Données Publique des Médicaments official site
It is known for being the official French government resource for medication information, centralizing data on medicines, active substances, and pathologies in a single searchable public database.
Sources: Base de Données Publique des Médicaments official site
Base de Données Publique des Médicaments scores 25/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Base de Données Publique des Médicaments has a weak AI-visibility profile at 25/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (15/100). It benefits from a Wikidata knowledge-graph entry, a Moz Domain Authority of 58/100 and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Base de Données Publique des Médicaments from memory (September 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Base de Données Publique des Médicaments: Matelas Mirabel (63/100), Labgesund (63/100), MedLever (63/100), MedPeer(メドピア) (63/100).
A step up - brands to learn from: ZT Corporate (71/100), Zaina AI (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.